Home
Jennewein Biotechnologie

Jennewein Biotechnologie Market Share Analysis for July 2026

die jennewein biotechnologie ist ein führendes unternehmen im bereich der produktion von seltenen monosacchariden sowie komplexen oligosacchariden. wir produzieren seltene funktionelle zucker für den einsatz in unterschiedlichen anwendungsbereichen wie zum beispiel der ernährung, pharmakologie und dermatologie.

Industry: N/A

Domainjennewein-biotech.de

Year Founded2005

Employees51 - 200

Annual Revenue$25M - $50M

Jennewein Biotechnologie

Jennewein Biotechnologie (including company regionals)

jennewein-biotech.de

See more website traffic and engagement information

Jennewein Biotechnologie Revenue up to July 2026 is 25M - 50M

revenue generated by Jennewein Biotechnologie top domains

Jennewein Biotechnologie top domains revenue over 3 years

Revenue for Jennewein Biotechnologie top domains

jennewein-biotech.de25M - 50M

See more with Sales Intelligence

Total visits to Jennewein Biotechnologie's top domains

Understand Jennewein Biotechnologie market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Jennewein Biotechnologie's top domains

Analyze Jennewein Biotechnologie engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Jennewein Biotechnologie's top domains

See how Jennewein Biotechnologie keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Jennewein Biotechnologie top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Jennewein Biotechnologie

These are the website technologies, by industry, used by Jennewein Biotechnologie top domains

Widget (4)

Twemoji

Mobile (2)

Meta Viewport

Multilingual (2)

Multilingual Support

Advertising (1)

DoubleClick

More Technologies

5

See all

News & Signals from Jennewein Biotechnologie

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHansen acquires Jennewein Biotech.Hansen has agreed to acquire all of the shares of Jennewein Biotechnologie, which is a leading player in the Human Milk Oligosaccharides (HMO) market.

NewsAnd Yumda acquired Jennewein Biotech on Sep 24th '20.Hansen”) has today entered into an agreement to acquire all of the shares of Jennewein Biotechnologie GmbH (“Jennewein”), which is a leading player in the Human Milk Oligosaccharides (“HMO”) market Hansen, said: “I am truly excited that Yumda has reached an agreement to acquire Jennewein.

NewsDairy Industries International acquires Jennewein Biotech.Mauricio Graber, CEO of Chr Hansen, said: “I am truly excited that Dairyindustries has reached an agreement to acquire Jennewein.